UW spins out PvP Biologics to develop treatment for celiac disease

PvP Biologics quietly spun out of the University of Washington last month and on Tuesday announced it is developing a treatment for celiac disease. The disease, which affect an estimated 2.4 million Americans, is an immune system reaction to gluten, a protein found in wheat, barley and rye. Sticking to a gluten-free diet is costly and challenging, says PvP Biologics. The company is developing an enzyme that can be taken orally and survive an d function in the harsh acidic environment of the stomach. David…
Source: bizjournals.com Health Care News Headlines - Category: Health Management Authors: Source Type: news